0001193125-16-454904.txt : 20160209 0001193125-16-454904.hdr.sgml : 20160209 20160209112106 ACCESSION NUMBER: 0001193125-16-454904 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160209 DATE AS OF CHANGE: 20160209 GROUP MEMBERS: ABERDARE GP III, L.L.C. GROUP MEMBERS: ABERDARE PARTNERS III, L.P. GROUP MEMBERS: PAUL H. KLINGENSTEIN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEVRO CORP CENTRAL INDEX KEY: 0001444380 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 562568057 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88537 FILM NUMBER: 161397949 BUSINESS ADDRESS: STREET 1: 4040 CAMPBELL AVENUE STREET 2: SUITE 210 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-251-0005 MAIL ADDRESS: STREET 1: 4040 CAMPBELL AVENUE STREET 2: SUITE 210 CITY: MENLO PARK STATE: CA ZIP: 94025 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Aberdare Ventures III LP CENTRAL INDEX KEY: 0001313414 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER STE 4000 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-392-7442 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER STE 4000 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 SC 13G/A 1 d136955dsc13ga.htm SC 13G/A SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c)

AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)

(Amendment No. 1) *

 

 

Nevro Corp.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

64157F 10 3

(CUSIP Number)

December 31, 2015

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP NO.  64157F 10 3   13 G   Page 2 of 9 Pages

 

  1   

NAMES OF REPORTING PERSONS.

 

Aberdare Ventures III, L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

SOLE VOTING POWER

 

0 shares    

   6   

SHARED VOTING POWER

 

0 shares    

   7   

SOLE DISPOSITIVE POWER

 

0 shares    

   8   

SHARED DISPOSITIVE POWER

 

0 shares    

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%    

12  

TYPE OF REPORTING PERSON*

 

PN    

 

(1) This Schedule 13G is filed by Aberdare Ventures III, L.P. (“AV III”), Aberdare Partners III, L.P. (“AP III”), Aberdare GP III, L.L.C. (“Aberdare GP III”), and Paul H. Klingenstein (“Klingenstein,” together with AV III, AP III and Aberdare GP III, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.


CUSIP NO.  64157F 10 3   13 G   Page 3 of 9 Pages

 

  1   

NAMES OF REPORTING PERSONS.

 

Aberdare Partners III, L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

SOLE VOTING POWER

 

0 shares    

   6   

SHARED VOTING POWER

 

0 shares    

   7   

SOLE DISPOSITIVE POWER

 

0 shares    

   8   

SHARED DISPOSITIVE POWER

 

0 shares    

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%    

12  

TYPE OF REPORTING PERSON*

 

PN    

 

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.


CUSIP NO.  64157F 10 3   13 G   Page 4 of 9 Pages

 

  1   

NAMES OF REPORTING PERSONS.

 

Aberdare GP III, L.L.C.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

SOLE VOTING POWER

 

0 shares    

   6   

SHARED VOTING POWER

 

0 shares    

   7   

SOLE DISPOSITIVE POWER

 

0 shares    

   8   

SHARED DISPOSITIVE POWER

 

0 shares    

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%    

12  

TYPE OF REPORTING PERSON*

 

OO

 

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.


CUSIP NO.  64157F 10 3   13 G   Page 5 of 9 Pages

 

  1   

NAMES OF REPORTING PERSONS.

 

Paul H. Klingenstein

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

SOLE VOTING POWER

 

0 shares    

   6   

SHARED VOTING POWER

 

0 shares    

   7   

SOLE DISPOSITIVE POWER

 

0 shares    

   8   

SHARED DISPOSITIVE POWER

 

0 shares    

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%    

12  

TYPE OF REPORTING PERSON*

 

IN

 

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.


Introductory Note: This Statement on Schedule 13G is filed on behalf of Aberdare Ventures III, L.P., Aberdare Partners III, L.P., Aberdare GP III, L.L.C. and Paul H. Klingenstein in respect of shares of Common Stock, par value $0.001 per share (“Common Stock”), of Nevro Corp. (the “Issuer”).

Item 1

 

(a)       Name of Issuer:    Nevro Corp.
(b)   Address of Issuer’s   
  Principal Executive Offices:    4040 Campbell Avenue, Menlo Park, California 94025

Item 2

 

(a)        Name of Person(s) Filing:   
  

Aberdare Ventures III, L.P. (“AV III”)

  
  

Aberdare Partners III, L.P. (“AP III”)

  
  

Aberdare GP III, L.L.C. (“Aberdare GP III”)

  
  

Paul H. Klingenstein (“Klingenstein”)

  
(b)    Address of Principal Business Office:    c/o Aberdare Ventures
      235 Montgomery Street, Suite 1230
      San Francisco, California 94104
(c)    Citizenship:   
  

AV III

   Delaware
  

AP III

   Delaware
  

Aberdare GP III

   Delaware
  

Klingenstein

   United States of America
(d)        Title of Class of Securities:    Common Stock
(e)    CUSIP Number:    64157F 10 3

 

Item 3 Not applicable.

 

Page 6 of 9 Pages


Item 4 Ownership.

The following information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2015:

 

Reporting Persons    Shares Held
Directly
     Sole Voting
Power
     Shared Voting
Power
     Sole
Dispositive
Power
     Shared
Dispositive
Power
     Beneficial
Ownership
     Percentage of
Class
 

AV III

     0         0         0         0         0         0         0.0

AP III

     0         0         0         0         0         0         0.0

Aberdare GP III

     0         0         0         0         0         0         0.0

Klingenstein

     0         0         0         0         0         0         0.0

 

Item 5 Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  x

 

Item 6 Ownership of More Than Five Percent on Behalf of Another Person.

Not applicable.

 

Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

 

Item 8 Identification and Classification of Members of the Group.

Not applicable.

 

Item 9 Notice of Dissolution of Group.

Not applicable.

 

Item 10 Certification.

Not applicable.

 

Page 7 of 9 Pages


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 9, 2016

 

/s/ Paul H. Klingenstein

Paul H. Klingenstein
ABERDARE VENTURES III, L.P.
By its General Partner, Aberdare GP III, L.L.C.
By:  

/s/ Paul H. Klingenstein

          Paul H. Klingenstein
          Manager
ABERDARE PARTNERS III, L.P.
By its General Partner, Aberdare GP III, L.L.C.
By:  

/s/ Paul H. Klingenstein

          Paul H. Klingenstein
          Manager
ABERDARE GP III, L.L.C.
By:  

/s/ Paul H. Klingenstein

          Paul H. Klingenstein
          Manager

Exhibit(s):

A - Joint Filing Statement

 

Page 8 of 9 Pages

EX-99.A 2 d136955dex99a.htm EX-A EX-A

EXHIBIT A

JOINT FILING STATEMENT

We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Nevro Corp. is filed on behalf of each of us.

Dated: February 9, 2016

 

/s/ Paul H. Klingenstein

Paul H. Klingenstein
ABERDARE VENTURES III, L.P.
By its General Partner, Aberdare GP III, L.L.C.
By:  

/s/ Paul H. Klingenstein

          Paul H. Klingenstein
          Manager
ABERDARE PARTNERS III, L.P.
By its General Partner, Aberdare GP III, L.L.C.
By:  

/s/ Paul H. Klingenstein

          Paul H. Klingenstein
          Manager
ABERDARE GP III, L.L.C.
By:  

/s/ Paul H. Klingenstein

          Paul H. Klingenstein
          Manager

 

Page 9 of 9 Pages